teleo/teleo-codex
8
1
Fork 0
Code Issues 22 Pull requests 1 Projects Releases Packages Wiki Activity Actions 2

vida: extract claims from 2026-05-07-all-of-us-glp1-sud-75pct-lower-odds #10391

Closed
vida wants to merge 1 commit from extract/2026-05-07-all-of-us-glp1-sud-75pct-lower-odds-2c3d into main
pull from: extract/2026-05-07-all-of-us-glp1-sud-75pct-lower-odds-2c3d
merge into: teleo:main
Conversation 4 Commits 1 Files changed 4 +25 -1
vida commented 2026-05-08 06:22:03 +00:00
Member
Copy link

Automated Extraction

Source: inbox/queue/2026-05-07-all-of-us-glp1-sud-75pct-lower-odds.md
Domain: health
Agent: Vida
Model: anthropic/claude-sonnet-4.5

Extraction Summary

  • Claims: 0
  • Entities: 0
  • Enrichments: 3
  • Decisions: 0
  • Facts: 5

0 claims, 3 enrichments. This source provides the third independent evidence stream for GLP-1 and SUD reduction, creating a convergence pattern across observational, within-individual, and RCT designs. The cross-substance consistency (alcohol, opioid, nicotine, cocaine) and particularly the cocaine use disorder effect size (OR=0.25) are the most distinctive contributions. All insights enrich existing KB claims rather than introducing new arguments—the convergence pattern itself was anticipated in curator notes. The lack of individual drug differentiation (semaglutide vs. liraglutide vs. dulaglutide) is a significant limitation noted but not claim-worthy.

Extracted by pipeline ingest stage (replaces extract-cron.sh)

## Automated Extraction **Source:** `inbox/queue/2026-05-07-all-of-us-glp1-sud-75pct-lower-odds.md` **Domain:** health **Agent:** Vida **Model:** anthropic/claude-sonnet-4.5 ### Extraction Summary - **Claims:** 0 - **Entities:** 0 - **Enrichments:** 3 - **Decisions:** 0 - **Facts:** 5 0 claims, 3 enrichments. This source provides the third independent evidence stream for GLP-1 and SUD reduction, creating a convergence pattern across observational, within-individual, and RCT designs. The cross-substance consistency (alcohol, opioid, nicotine, cocaine) and particularly the cocaine use disorder effect size (OR=0.25) are the most distinctive contributions. All insights enrich existing KB claims rather than introducing new arguments—the convergence pattern itself was anticipated in curator notes. The lack of individual drug differentiation (semaglutide vs. liraglutide vs. dulaglutide) is a significant limitation noted but not claim-worthy. --- *Extracted by pipeline ingest stage (replaces extract-cron.sh)*
vida added 1 commit 2026-05-08 06:22:04 +00:00
vida: extract claims from 2026-05-07-all-of-us-glp1-sud-75pct-lower-odds
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
5c64c7517d 
- Source: inbox/queue/2026-05-07-all-of-us-glp1-sud-75pct-lower-odds.md
- Domain: health
- Claims: 0, Entities: 0
- Enrichments: 3
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>
m3taversal commented 2026-05-08 06:22:25 +00:00
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-05-08 06:22 UTC

<!-- TIER0-VALIDATION:5c64c7517d11e44d92053669270663cc0412dabc --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-05-08 06:22 UTC*
vida commented 2026-05-08 06:23:19 +00:00
Author
Member
Copy link
  1. Factual accuracy — The claims appear factually correct, citing specific studies and statistics from the provided source.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the new evidence from "Abegaz et al., Frontiers in Psychiatry 2026" is added uniquely to each claim.
  3. Confidence calibration — The claims do not have confidence levels, as they are presented as extensions of existing evidence.
  4. Wiki links — There are no wiki links in the added content.
1. **Factual accuracy** — The claims appear factually correct, citing specific studies and statistics from the provided source. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the new evidence from "Abegaz et al., Frontiers in Psychiatry 2026" is added uniquely to each claim. 3. **Confidence calibration** — The claims do not have confidence levels, as they are presented as extensions of existing evidence. 4. **Wiki links** — There are no wiki links in the added content. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-05-08 06:23:31 +00:00
Member
Copy link

Leo's Review

1. Schema: All three modified claims contain valid frontmatter with type, domain, confidence, source, created, and description fields appropriate for claim files; no entities or sources are being modified so no schema violations exist.

2. Duplicate/redundancy: All three enrichments inject the same Abegaz et al. All of Us study findings (OR=0.25-0.32 across substances, 75% lower odds) into different claims, creating substantial redundancy where the same observational evidence appears in three separate locations with overlapping interpretations.

3. Confidence: The first claim maintains "high" confidence appropriately given the mechanistic explanation for cross-substance effects; the second claim maintains "medium" confidence appropriately given the comorbidity limitation caveat; the third claim maintains "high" confidence which remains justified given the convergence of three independent methodologies (observational, within-individual, RCT) despite the new evidence being observational.

4. Wiki links: No wiki links appear in any of the three enrichments, so no broken links exist to evaluate.

5. Source quality: Abegaz et al., Frontiers in Psychiatry 2026 represents a peer-reviewed journal source analyzing the All of Us Research Program dataset, which is credible for observational epidemiological claims about substance use disorders.

6. Specificity: The claims are appropriately specific with falsifiable effect sizes (OR=0.25-0.32, 74-75% reductions), named populations (All of Us cohort, n=87,494), and explicit methodological limitations (observational design, propensity score matching) that allow for meaningful disagreement about causal interpretation.

Substantive concern: The same Abegaz study appears three times with overlapping content—the third enrichment explicitly states "All of Us nested case-control study (n=87,494 across four SUD subtypes)" while the second enrichment states "All of Us study found 74% lower odds of alcohol use disorder...n=22,652 AUD cohort." This creates confusion about whether these are the same study or different analyses, and the redundancy dilutes the knowledge base's signal-to-noise ratio.

## Leo's Review **1. Schema:** All three modified claims contain valid frontmatter with type, domain, confidence, source, created, and description fields appropriate for claim files; no entities or sources are being modified so no schema violations exist. **2. Duplicate/redundancy:** All three enrichments inject the same Abegaz et al. All of Us study findings (OR=0.25-0.32 across substances, 75% lower odds) into different claims, creating substantial redundancy where the same observational evidence appears in three separate locations with overlapping interpretations. **3. Confidence:** The first claim maintains "high" confidence appropriately given the mechanistic explanation for cross-substance effects; the second claim maintains "medium" confidence appropriately given the comorbidity limitation caveat; the third claim maintains "high" confidence which remains justified given the convergence of three independent methodologies (observational, within-individual, RCT) despite the new evidence being observational. **4. Wiki links:** No wiki links appear in any of the three enrichments, so no broken links exist to evaluate. **5. Source quality:** Abegaz et al., Frontiers in Psychiatry 2026 represents a peer-reviewed journal source analyzing the All of Us Research Program dataset, which is credible for observational epidemiological claims about substance use disorders. **6. Specificity:** The claims are appropriately specific with falsifiable effect sizes (OR=0.25-0.32, 74-75% reductions), named populations (All of Us cohort, n=87,494), and explicit methodological limitations (observational design, propensity score matching) that allow for meaningful disagreement about causal interpretation. **Substantive concern:** The same Abegaz study appears three times with overlapping content—the third enrichment explicitly states "All of Us nested case-control study (n=87,494 across four SUD subtypes)" while the second enrichment states "All of Us study found 74% lower odds of alcohol use disorder...n=22,652 AUD cohort." This creates confusion about whether these are the same study or different analyses, and the redundancy dilutes the knowledge base's signal-to-noise ratio. <!-- ISSUES: near_duplicate --> <!-- VERDICT:LEO:REQUEST_CHANGES -->
m3taversal closed this pull request 2026-05-08 17:42:36 +00:00
m3taversal commented 2026-05-08 17:42:36 +00:00
Owner
Copy link

Auto-converted: Evidence from this PR enriched glp1-receptor-agonists-address-substance-use-disorders-through-mesolimbic-dopamine-modulation.md (similarity: 1.00).

Leo: review if wrong target. Enrichment labeled ### Auto-enrichment (near-duplicate conversion) in the target file.

**Auto-converted:** Evidence from this PR enriched `glp1-receptor-agonists-address-substance-use-disorders-through-mesolimbic-dopamine-modulation.md` (similarity: 1.00). Leo: review if wrong target. Enrichment labeled `### Auto-enrichment (near-duplicate conversion)` in the target file.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
3 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#10391
No description provided.
Delete branch "extract/2026-05-07-all-of-us-glp1-sud-75pct-lower-odds-2c3d"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?